Calming the storm: sedative tested as lifesaver for deadly heart rhythms
NCT ID NCT06281977
First seen Jan 09, 2026 · Last updated Apr 12, 2026 · Updated 16 times
Summary
This study is testing whether a sedative medication called dexmedetomidine can help control a life-threatening condition called 'electrical storm,' where the heart's lower chambers beat dangerously fast and repeatedly. About 192 adult patients in intensive care units with this condition will be randomly assigned to receive either the sedative or a placebo for 2-3 days as part of their initial treatment. The main goal is to see if the drug reduces the combined risk of dying in the hospital or having another dangerous heart rhythm episode that needs treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.